サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1518569

商業バイオテクノロジー向け分離システム市場レポート：方法・用途・地域別、2024年～2032年

Separation Systems for Commercial Biotechnology Market Report by Methods (Modern Methods, Conventional Methods), Application (Pharmaceutical, Food and Cosmetics, Agriculture, and Others), and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 138 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.94円
商業バイオテクノロジー向け分離システム市場レポート：方法・用途・地域別、2024年～2032年
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の商業バイオテクノロジー向け分離システム市場規模は2023年に268億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに429億米ドルに達し、2024年から2032年の間に5.24％の成長率（CAGR）を示すと予測しています。

市場規模 年平均成長率（CAGR）グラフ | 商業バイオテクノロジー向け分離システム市場レポート：方法・用途・地域別、2024年～2032年

商業バイオテクノロジー用の分離システムは、生化学、診断試薬、バイオ医薬品を含む複雑な混合物や溶液から生物学的産物を精製・分離するために使用される溶液を指します。分離は、生成物の静電荷、密度、形状、極性、溶解性、拡散性、揮発性に基づいて行われます。分離には、クロマトグラフ、メンブレン、フィルター、遠心分離機、バイオチップ、マイクロアレイなど、さまざまな機器や装置が使用されます。これらのソリューションは、樹脂の生産性を向上させ、回収率を高め、廃棄物の発生や洗浄水の使用を最小限に抑えます。その結果、分離システムは、製薬、飲食品、化粧品、農業など、さまざまな産業で幅広い用途を見出しています。

商業バイオテクノロジー向け分離システム市場動向：

世界の製薬業界の著しい成長は、市場の明るい見通しを生み出す重要な要因のひとつです。慢性疾患の増加に伴い、個別化医薬品、バイオ医薬品、細胞ベースの治療に対する需要が高まっており、これが商業バイオテクノロジー向け分離システムの需要に影響を与えています。さらに、プラスチックや化学製品の商業生産に磁気分離装置が広く採用されていることも、市場成長の原動力となっています。さらに、簡略化された手順でバイオハザードの製品別を除去する革新的な上流バイオプロセス技術の開発など、さまざまな技術的進歩が成長を促進する要因となっています。バイオテクノロジー研究所や研究機関もまた、高感度かつ高分子の分離のために、新しい高性能ガスクロマトグラフや超臨界流体クロマトグラフ、遠心分離、電気泳動装置を使用しています。その他にも、特に新興経済諸国におけるヘルスケアインフラの改善や、バイオテクノロジー分野における広範な研究開発（R&D）などが、市場の成長を後押しすると予想されます。

本レポートで扱う主な質問

  • 2023年における世界の商業バイオテクノロジー向け分離システム市場の市場規模は？
  • 2024-2032年における世界の商業バイオテクノロジー向け分離システム市場の予想成長率は？
  • 世界の商業バイオテクノロジー向け分離システム市場を牽引する主要因は？
  • 世界の商業バイオテクノロジー向け分離システム市場に対するCOVID-19の影響は？
  • 世界の商業バイオテクノロジー向け分離システム市場の用途別内訳は？
  • 世界の商業バイオテクノロジー向け分離システム市場の主要地域は？
  • 世界の商業バイオテクノロジー向け分離システム市場の主要プレーヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の商業バイオテクノロジー向け分離システム市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：方法別

  • 現代的な方法
    • 市場動向
    • 主要セグメント
      • マイクロアレイ
      • ラボオンチップ
      • 磁気分離
      • その他
    • 市場予測
  • 従来の方法
    • 市場動向
    • 主要セグメント
      • クロマトグラフィー
      • フローサイトメトリー
      • 膜ろ過
      • その他
    • 市場予測

第7章 市場内訳：用途別

  • 製薬
    • 市場動向
    • 主要セグメント
      • ワクチン
      • タンパク質
      • ホルモンとインスリン
      • 酵素
      • ヒト血漿分画
      • 哺乳類細胞培養
    • 市場予測
  • 食品・化粧品
    • 市場動向
    • 市場予測
  • 農業
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第9章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies Inc.
    • Becton Dickinson and Company
    • Bio-Rad Laboratories Inc.
    • Hitachi Ltd.
    • Merck KGaA
    • Pall Corporation（Danaher Corporation）
    • PerkinElmer Inc.
    • Qiagen N.V
    • Repligen Corporation
    • Sartorius AG
    • Shimadzu Corporation
    • Thermo Fisher Scientific
図表

List of Figures

  • Figure 1: Global: Separation Systems for Commercial Biotechnology Market: Major Drivers and Challenges
  • Figure 2: Global: Separation Systems for Commercial Biotechnology Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Separation Systems for Commercial Biotechnology Market: Breakup by Methods (in %), 2023
  • Figure 5: Global: Separation Systems for Commercial Biotechnology Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Separation Systems for Commercial Biotechnology Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Separation Systems for Commercial Biotechnology (Modern Methods) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Separation Systems for Commercial Biotechnology (Modern Methods) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Separation Systems for Commercial Biotechnology (Conventional Methods) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Separation Systems for Commercial Biotechnology (Conventional Methods) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Separation Systems for Commercial Biotechnology (Pharmaceutical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Separation Systems for Commercial Biotechnology (Pharmaceutical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Separation Systems for Commercial Biotechnology (Food and Cosmetics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Separation Systems for Commercial Biotechnology (Food and Cosmetics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Separation Systems for Commercial Biotechnology (Agriculture) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Separation Systems for Commercial Biotechnology (Agriculture) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Separation Systems for Commercial Biotechnology (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Separation Systems for Commercial Biotechnology (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: North America: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: North America: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: United States: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: United States: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Canada: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Canada: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Asia-Pacific: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Asia-Pacific: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: China: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: China: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Japan: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Japan: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: India: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: India: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: South Korea: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: South Korea: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Australia: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Australia: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Indonesia: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Indonesia: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Others: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Others: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Europe: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Europe: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Germany: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Germany: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: France: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: France: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: United Kingdom: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: United Kingdom: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Italy: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Italy: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Spain: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Spain: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Russia: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Russia: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Others: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Others: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Latin America: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Latin America: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Brazil: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Brazil: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Mexico: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Mexico: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Others: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Others: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Middle East and Africa: Separation Systems for Commercial Biotechnology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Middle East and Africa: Separation Systems for Commercial Biotechnology Market: Breakup by Country (in %), 2023
  • Figure 67: Middle East and Africa: Separation Systems for Commercial Biotechnology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Global: Separation Systems for Commercial Biotechnology Industry: SWOT Analysis
  • Figure 69: Global: Separation Systems for Commercial Biotechnology Industry: Value Chain Analysis
  • Figure 70: Global: Separation Systems for Commercial Biotechnology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Separation Systems for Commercial Biotechnology Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Separation Systems for Commercial Biotechnology Market Forecast: Breakup by Methods (in Million US$), 2024-2032
  • Table 3: Global: Separation Systems for Commercial Biotechnology Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Separation Systems for Commercial Biotechnology Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Separation Systems for Commercial Biotechnology Market: Competitive Structure
  • Table 6: Global: Separation Systems for Commercial Biotechnology Market: Key Players
目次
Product Code: SR112024A5734

The global separation systems for commercial biotechnology market size reached US$ 26.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 42.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.24% during 2024-2032.

The separation systems for commercial biotechnology refer to the solutions used for the purification and separation of biological products from complex mixtures and solutions, including biochemicals, diagnostic reagents and biopharmaceuticals. The separation is based on the electrostatic charge, density, shape, polarity, solubility, diffusivity and volatility of the product. It involves the use of various equipment and devices, such as chromatographs, membranes, filters, centrifuges, biochips and microarrays. These solutions offer improved resin productivity, higher recovery and minimal waste generation and wash water usage. As a result, separation systems find extensive applications across various industries, including pharmaceutical, food and beverage, cosmetic and agriculture.

Separation Systems for Commercial Biotechnology Market Trends:

Significant growth in the pharmaceutical industry across the globe is one of the key factors creating a positive outlook for the market. With the increasing prevalence of chronic medical ailments, there is a rising demand for personalized drugs, biopharmaceuticals and cell-based therapies, which is impacting the demand for separation systems for commercial biotechnology. Moreover, the widespread adoption of magnetic separators for the commercial production of plastics and chemicals is providing a thrust to the market growth. Additionally, various technological advancements, such as the development of innovative upstream bioprocessing technologies that facilitate in the elimination of biohazardous by-products using simplified procedures, are acting as growth-inducing factors. Biotechnological institutes and research organizations are also using novel high-performance gas and supercritical fluid chromatography, centrifugation and electrophoresis equipment for the separation of sensitive and large molecules. Other factors, including improvements in the healthcare infrastructure, especially in the developing economies, along with extensive research and development (R&D) in the field of biotechnology, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global separation systems for commercial biotechnology market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on methods and application.

Breakup by Methods:

Modern Methods

Microarray

Lab-on-a-Chip

Magnetic Separation

Others

Conventional Methods

Chromatography

Flow Cytometry

Membrane Filtration

Others

Breakup by Application:

Pharmaceutical

Vaccines

Proteins

Hormones and Insulin

Enzymes

Human Blood Plasma Fractionation

Mammalian Cell Cultures

Food and Cosmetics

Agriculture

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Hitachi Ltd., Merck KGaA, Pall Corporation (Danaher Corporation), PerkinElmer Inc., Qiagen N.V, Repligen Corporation, Sartorius AG, Shimadzu Corporation and Thermo Fisher Scientific.

Key Questions Answered in This Report

  • 1. What was the size of the global separation systems for commercial biotechnology market in 2023?
  • 2. What is the expected growth rate of the global separation systems for commercial biotechnology market during 2024-2032?
  • 3. What are the key factors driving the global separation systems for commercial biotechnology market?
  • 4. What has been the impact of COVID-19 on the global separation systems for commercial biotechnology market?
  • 5. What is the breakup of the global separation systems for commercial biotechnology market based on the methods?
  • 6. What is the breakup of the global separation systems for commercial biotechnology market based on the application?
  • 7. What are the key regions in the global separation systems for commercial biotechnology market?
  • 8. Who are the key players/companies in the global separation systems for commercial biotechnology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Separation Systems for Commercial Biotechnology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Methods

  • 6.1 Modern Methods
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Microarray
      • 6.1.2.2 Lab-on-a-Chip
      • 6.1.2.3 Magnetic Separation
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Conventional Methods
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Chromatography
      • 6.2.2.2 Flow Cytometry
      • 6.2.2.3 Membrane Filtration
      • 6.2.2.4 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Pharmaceutical
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Vaccines
      • 7.1.2.2 Proteins
      • 7.1.2.3 Hormones and Insulin
      • 7.1.2.4 Enzymes
      • 7.1.2.5 Human Blood Plasma Fractionation
      • 7.1.2.6 Mammalian Cell Cultures
    • 7.1.3 Market Forecast
  • 7.2 Food and Cosmetics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Agriculture
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Becton Dickinson and Company
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Bio-Rad Laboratories Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Hitachi Ltd.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Merck KGaA
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Pall Corporation (Danaher Corporation)
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 SWOT Analysis
    • 13.3.7 PerkinElmer Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
    • 13.3.8 Qiagen N.V
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Repligen Corporation
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 Sartorius AG
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Shimadzu Corporation
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis
    • 13.3.12 Thermo Fisher Scientific
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
      • 13.3.12.4 SWOT Analysis